Norges Bank
ACOR

Norges Bank’s Acorda Therapeutics ACOR Stock Holding History

Norges Bank’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,462
Closed -$603K – 2086
2019
Q4 		$603K Sell
2,462
-1,706
-41% -$430K ﹤0.01% 2046
2019
Q3 		$1.44M Sell
4,168
-3,682
-47% -$2M ﹤0.01% 2013
2019
Q2 		$7.22M Hold
7,850
– – ﹤0.01% 1884
2019
Q1 		$12.5M Hold
7,850
– – ﹤0.01% 1725
2018
Q4 		$14.7M Hold
7,850
– – 0.01% 1572
2018
Q3 		$18.5M Hold
7,850
– – 0.01% 1574
2018
Q2 		$27M Hold
7,850
– – 0.01% 1306
2018
Q1 		$22.3M Sell
7,850
-215
-3% -$644K 0.01% 1360
2017
Q4 		$20.8M Buy
8,065
+3,395
+73% +$9.65M 0.01% 1446
2017
Q3 		$13.3M Hold
4,670
– – 0.01% 1647
2017
Q2 		$11M Buy
4,670
+547
+13% +$1.08M ﹤0.01% 1699
2017
Q1 		$10.4M Buy
4,123
+520
+14% +$1.5M ﹤0.01% 1729
2016
Q4 		$8.13M Buy
3,603
+552
+18% +$1.31M ﹤0.01% 1766
2016
Q3 		$7.3M Buy
3,051
+244
+9% +$728K ﹤0.01% 1777
2016
Q2 		$8.59M Hold
2,807
– – ﹤0.01% 1680
2016
Q1 		$8.91M Hold
2,807
– – ﹤0.01% 1629
2015
Q4 		$14.4M Hold
2,807
– – 0.01% 1362
2015
Q3 		$8.93M Hold
2,807
– – ﹤0.01% 1628
2015
Q2 		$11.2M Sell
2,807
-392
-12% -$1.51M 0.01% 1557
2015
Q1 		$12.8M Sell
3,199
-167
-5% -$765K 0.01% 1504
2014
Q4 		$16.5M Buy
3,366
+255
+8% +$1.09M 0.01% 1332
2014
Q3 		$12.6M Sell
3,111
-3,112
-50% -$11.7M 0.01% 1440
2014
Q2 		$25.2M Buy
6,223
+3,411
+121% +$13.9M 0.01% 1487
2014
Q1 		$12.8M Hold
2,812
– – 0.01% 1428
2013
Q4 		$9.85M Hold
2,812
– – 0.01% 1582
2013
Q3 		$11.6M Buy
2,812
+382
+16% +$1.65M 0.01% 1467
2013
Q2 		$9.62M Buy
+2,430
New +$10M 0.01% 1494

Other funds holding ACOR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank's ACOR Position: Q1 2020 in Review

Norges Bank sold out of Acorda Therapeutics (ACOR) in Q1 2020, closing a stake of 2,462 shares — an estimated $603K sold.

Norges Bank first reported a position in ACOR in Q2 2013 and held it in 27 quarters. The position peaked at $27M in Q2 2018. 106 funds tracked by Wall St. Rank hold ACOR as of Q1 2020.

  • Norges Bank reported no remaining Acorda Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Norges Bank sold 2,462 Acorda Therapeutics shares in Q1 2020, an estimated $603K.
  • Norges Bank first reported a position in Acorda Therapeutics in Q2 2013 and held it in 27 quarters.
  • Norges Bank's Acorda Therapeutics position peaked at $27M in Q2 2018.
  • 106 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2020.

Based on Norges Bank's 13F filing for Q1 2020, filed 8 May 2020.